• PNS118 VALUE-BASED REIMBURSEMENT UNDER THE INPATIENT PROSPECTIVE PAYMENT SYSTEM IN JAPAN

    May 1, 2019, 00:00

  • PND6 PARKINSON'S DISEASE PROGRESSION: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PNS91 COMPARING PAYER AND MANUFACTURER EXPERIENCES WITH HCEI AND PIE AFTER PASSAGE OF THE 21ST CENTURY CURES ACT

    May 1, 2019, 00:00

  • PDG89 USING THE REAL WORLD DATA TO IDENTIFY THE ASSOCIATION BETWEEN THE MOST COMMON SYMPTOM CLUSTERS OF DRUG ADRS AND NUMBERS OF DRUGS PER PATIENT REGIMEN IN A MEDICAID POPULATION

    May 1, 2019, 00:00

  • PNS145 PATIENTS HAVE LITTLE, IF ANY, INPUT INTO COMMERCIAL HEALTH PLAN SPECIALTY DRUG COVERAGE POLICY DEVELOPMENT

    May 1, 2019, 00:00

  • PMU50 COMPARING UTILIZATION, COST AND QUALITY IN DUAL ELIGIBLE MEDICARE ADVANTAGE AND FEE-FOR-SERVICE MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • Looking Backward 2143-1943: The Rise and Fall of the RCT

    May 1, 2019, 00:00

  • PCN294 DERIVATION OF UTILITY VALUES FOR PATIENTS WITH ADVANCED HEPATOCELULAR CARCINOMA BASED ON HRQOL DATA FROM THE PHASE 3 CELESTIAL TRIAL

    May 1, 2019, 00:00

  • PCN317 REAL-WORLD STUDY OF METASTATIC MERKEL CELL CARCINOMA PATIENTS RECEIVING CHECKPOINT INHIBITORS (CPIS) VS. CHEMOTHERAPY TREATMENTS

    May 1, 2019, 00:00

  • PDB88 THE IMPACT OF PHARMACIST-DELIVERED MEDICATION THERAPY MANAGEMENT (MTM) ON OUTCOMES FOR PATIENTS WITH DIABETES: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • Medical Devices - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PNS179 HTA IMPLEMENTATION IN MIDDLE EAST AND NORTH AFRICA: COMPARISON OF CURRENT AND PREFERRED STATUS

    May 1, 2019, 00:00

  • PND61 LITERATURE REVIEW ON THE POTENTIAL SOCIETAL IMPACT OF DISEASE-MODIFYING THERAPIES IN ALZHEIMER€™S DISEASE

    May 1, 2019, 00:00

  • PDG58 CLOSING THE MEDICARE PART D COVERAGE GAP: TRENDS IN DRUG UTILIZATION AND EXPENDITURES, 2008- 2015

    May 1, 2019, 00:00

  • PDG31 ESTIMATING COSTS OF CLUSTERED OUTPATIENT ADVERSE DRUG REACTIONS WITHIN THE VETERANS HEALTH ADMINISTRATION USING THE VA ADVERSE DRUG EVENT REPORTING SYSTEM

    May 1, 2019, 00:00

  • PNS261 HOW DOES MACHINE-LEARNING COMPARE TO AN INCOMING MEDICAL STUDENT IN EXTRACTING OUTCOMES RESULTS FROM ABSTRACTS?

    May 1, 2019, 00:00

  • AD3 FOOD INSECURE CANCER SURVIVORS ARE MORE LIKELY TO FORGO OR DELAY MEDICAL CARE

    May 1, 2019, 00:00

  • PDG4 THE IMPACT OF ANTIBIOTIC TREATMENT TIME AND CLASS OF ANTIBIOTIC FOR ACUTE OTITIS MEDIA INFECTIONS ON THE RISK OF REVISITS

    May 1, 2019, 00:00

  • PNS97 LEVERAGING DATA-DRIVEN INSIGHTS TO SUPPORT DEVELOPMENT OF TARGETED SUPPLEMENTAL BENEFITS UNDER NEWLY EXPANDED FLEXIBILITIES IN MEDICARE ADVANTAGE TO IMPROVE OUTCOMES IN HIGH-COST, HIGH-NEED BENEFICIARIES

    May 1, 2019, 00:00

  • PNS113 THE 2019 UNITED STATES PAYOR LANDSCAPE: TRENDS AND RESULTS FROM SURVEYS ON FORMULARY MANAGEMENT

    May 1, 2019, 00:00

  • PNS211 ASSESSING POPULATION-ADJUSTED INDIRECT COMPARISON METHODS (MATCHING-ADJUSTED INDIRECT COMPARISON AND SIMULATED TREATMENT COMPARISON) USING MONTE-CARLO SIMULATIONS

    May 1, 2019, 00:00

  • PCV34 ANNUAL HEALTH INSURANCE TREATMENT COST OF PHLEBITIS AND THROMBOPHLEBITIS: A NATIONWIDE, REAL-WORLD COST OF ILLNESS STUDY

    May 1, 2019, 00:00

  • PDG90 OPIOID USE AMONG MIGRAINE PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT (ED) OF A LARGE TERTIARY CARE INTEGRATED DELIVERY NETWORK IN TEXAS

    May 1, 2019, 00:00

  • PMU81 INCORPORATING HEALTH TECHNOLOGY ASSESSMENT INTO LABORATORY MEDICINE AT UW MEDICINE

    May 1, 2019, 00:00

  • PIH33 COST MINIMIZATION ANALYSIS OF HIGH PURITY URINARY HUMAN FOLLICLE-STIMULATING HORMONE FOR THE CONTROLLED OVARIAN STIMULATION IN IN-VITRO FERTILIZATION IN CHINA

    May 1, 2019, 00:00

  • PMU18 TREATMENT PATTERNS, HEALTH CARE RESOURCE USE, AND FINANCIAL IMPACT OF CADASIL IN THE UNITED STATES

    May 1, 2019, 00:00

  • PMU84 TARGETED LITERATURE REVIEW OF TIME UTILIZATION ASSOCIATED WITH THE USE OF PREFILLED SYRINGES VERSUS CONVENTIONAL SYRINGES

    May 1, 2019, 00:00

  • PNS212 AUTOMATING VARIABLE SELECTION IN META-REGRESSION

    May 1, 2019, 00:00

  • PNS263 FREQUENCIES OF CONSECUTIVELY MISSED DAILY DOSES OF ESCITALOPRAM

    May 1, 2019, 00:00

  • PCN236 COST-EFFECTIVENESS OF LENALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN THE CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA BUT INELIGIBLE FOR STEM CELL TRANSPLANT THERAPY

    May 1, 2019, 00:00

  • PIN48 A COST-EFFECTIVENESS ANALYSIS FOR INFLUENZA VIRUS INFECTION WITH OSELTAMIVIR OR BALOXAVIR IN JAPAN

    May 1, 2019, 00:00

  • PIN41 HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV15) SEROTYPES IN CHILDREN IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY

    May 1, 2019, 00:00

  • PDG72 DETERMINANTS OF AN EFFICIENT MODEL OF EXTENDED-RELEASE NALTREXONE INITIATION FOR THE TREATMENT OF OPIOID USE DISORDER

    May 1, 2019, 00:00

  • PMH65 ASSESSMENT OF OUTCOMES AND SYMPTOM SEVERITY IN SCHIZOPHRENIA PATIENTS ACCORDING TO PHYSICIAN PERCEPTION OF ILLNESS

    May 1, 2019, 00:00

  • PCV52 PRESCRIBING AND EXPENDITURES FOR PCSK9 INHIBITORS IN THE MEDICARE PART D POPULATION IN 2016

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Health Technology Assessment

    May 1, 2019, 00:00

  • PNS46 INTERVENTION USING PHARMACLOUD SYSTEM TO REDUCE POLYPHARMACY AND HEALTHCARE SPENDING

    May 1, 2019, 00:00

  • PIN94 MEASURING ADHERENCE TO TREATMENT IN HIV USING A REGIMEN BASED APPROACH

    May 1, 2019, 00:00

  • PNS44 A FRAMEWORK FOR ESTIMATING THE ECONOMIC BURDEN OF MEDICATION ERRORS WITHIN US ACUTE CARE FACILITIES

    May 1, 2019, 00:00

  • PMU75 EMERGING TRENDS IN US HTA: A SYSTEMATIC REVIEW OF ICER VALUE ASSESSMENTS TO IDENTIFY FACTORS ASSOCIATED WITH RECOMMENDATIONS

    May 1, 2019, 00:00

  • PIN87 EVALUATION OF THE EFFECTIVENESS OF CLINICAL PHARMACISTS’ CONSULTATION IN THE TREATMENT OF INFECTIOUS DISEASES: A SINGLE-ARM, PROSPECTIVE COHORT STUDY

    May 1, 2019, 00:00

  • PIN22 COST-EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C TREATMENT-NAIVE PATIENTS IN CHINA

    May 1, 2019, 00:00

  • PCV82 FACTORS ASSOCIATED WITH UNPLANNED 30-DAY HEART FAILURE READMISSION RATES AMONG MEDICARE AND MEDICAID PATIENTS IN TEXAS

    May 1, 2019, 00:00

  • PCN268 ASSOCIATION BETWEEN ADHERENCE TO ORAL HORMONE THERAPY AND TYPE OF ORAL HORMONE THERAPY IN MEDICARE BENEFICIARIES WITH HORMONE RECEPTOR POSITIVE BREAST CANCER

    May 1, 2019, 00:00

  • PCV5 PREVALENCE OF FOUR STATIN BENEFIT GROUPS IN A POPULATION OF THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2019, 00:00

  • AD4 THE IMPACT OF MEDICARE STAR RATING ADHERENCE MEASURES ON MEDICATION ADHERENCE FOR TARGETED AND NON-TARGETED MEDICATIONS

    May 1, 2019, 00:00

  • PMU69 INTERPROFESSIONAL CARE TRANSITIONS CLINIC IMPACT ON HEALTHCARE COSTS

    May 1, 2019, 00:00

  • Neurological Disorders - Health Technology Assessment

    May 1, 2019, 00:00

  • PMU33 ASSESSING NIGERIAN PHARMACISTS' FAMILIARITY AND EDUCATIONAL NEEDS REGARDING DISASTER EMERGENCY PREPAREDNESS COMPETENCIES

    May 1, 2019, 00:00

  • PIH51 A PILOT STUDY ASSESSING THE IMPACT OF ADVANCED PHARMACISTS-DELIVERED PATIENT-CENTERED CARE ON HEALTH OUTCOMES FOR HOSPITALIZED GERIATRICS PATIENTS

    May 1, 2019, 00:00

  • PNS253 HOW TO IDENTIFY AND DEAL WITH NUMERICAL INCONSISTENCIES IN ELICITED HEALTH STATE UTILITIES

    May 1, 2019, 00:00

  • PNS31 QUALITY OF PUBLISHED REAL WORLD EVIDENCE ARTICLES BASED ON RETROSPECTIVE DATABASE ANALYSIS USING THE STRWE-RETRO CHECKLIST

    May 1, 2019, 00:00

  • PDG17 COST-EFFECTIVENESS OF THE SECOND LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2019, 00:00

  • PMH5 HEALTH-RELATED QUALITY OF LIFE IN VETERANS AND NON-VETERANS WITH DEPRESSION

    May 1, 2019, 00:00

  • PMU52 STEP THERAPY AS AN APPROACH TO ADDRESS HEALTH CARE COSTS: PRINCIPLES, LEGISLATION AND PATIENT OUTCOMES

    May 1, 2019, 00:00

  • PMU29 IMPACT OF UNCONVENTIONAL NATURAL GAS OR PETROLEUM HYDRAULIC FRACTURING “FRACKING†ON HUMAN HEALTH: A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2019, 00:00

  • NO Specific Disease - Organizational Practices

    May 1, 2019, 00:00

  • PMD35 POTENTIAL COST SAVINGS IN TREATMENT OF CHRONIC WOUNDS WITH FIRST WOUND BED CONFORMING WOUND DRESSING

    May 1, 2019, 00:00

  • PMU54 DEVELOPMENT OF EXTENDED PHARMACY REIMBURSEMENT PROGRAM IN UKRAINE: EVIDENCE FROM THE ANALYSIS OF CENTRAL PROCUREMENT PROGRAMS

    May 1, 2019, 00:00

  • PCV8 HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS NEWLY TREATED FOR PULMONARY ARTERIAL HYPERTENSION IN A REAL-WORLD DATABASE REPRESENTING A LARGE US HEALTH PLAN

    May 1, 2019, 00:00

  • PDB50 SELF-MONITORING BLOOD GLUCOSE AND ECONOMIC OUTCOMES IN PEOPLE WITH DIABETES

    May 1, 2019, 00:00

  • PDB6 EFFECTIVENESS OF INSULIN PLUS OFF LABEL USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS VERSUS INSULIN ALONE IN TYPE 1 DIABETES: A REAL-WORLD OBSERVATIONAL ANALYSIS

    May 1, 2019, 00:00

  • PNS15 PRAGMATIC ARTIFICIAL INTELLIGENCE-BASED REFERENCE SCREENING IN SYSTEMATIC REVEIWS. ARE TWO ROBOTS BETTER THAN ONE?

    May 1, 2019, 00:00

  • AD2 EXAMINING THE ASSOCIATION BETWEEN PROVIDER OUTREACH AND PATIENTS' STATIN REFILL BEHAVIOR FOR PATIENTS WITHIN A MEDICARE ADVANTAGE WITH PRESCRIPTION DRUG (MAPD) COVERAGE POPULATION

    May 1, 2019, 00:00

  • PCN302 COMPARING SERVICE UTILIZATION AND COSTS FOR MEDICARE FFS PATIENTS WITH METASTATIC PANCREATIC CANCER BY CHEMOTHERAPY REGIMEN AND LINE OF THERAPY

    May 1, 2019, 00:00

  • PMU40 RISK FACTORS OF FLUOROPYRIMIDINE-INDUCED CARDIOTOXICITY AMONG CANCER SURVIVORS: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PDB38 REAL-WORLD COMPARISON OF HOSPITALIZATION COSTS FOR HEART FAILURE IN T2DM PATIENTS WITH CARDIOVASCULAR DISEASE TREATED WITH CANAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS

    May 1, 2019, 00:00

  • PDB122 ANTIDIABETIC DRUG PERSISTENCE AND SWITCHING PATTERNS: A RETROSPECTIVE CLAIMS STUDY

    May 1, 2019, 00:00

  • PCN311 CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA AFTER PROGRESSION ON PLATINUM-BASED THERAPY: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANA ...

    May 1, 2019, 00:00

  • PCV2 UNMET NEEDS FOR LIPID-LOWERING THERAPY IN CARDIOVASCULAR EVENTS REDUCTION

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

    May 1, 2019, 00:00

  • PCN282 EXPLORATORY ANALYSIS OF ADHERENCE TO ANTICANCER THERAPIES IN METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PDB67 DIABETES MELLITUS : A SYNONYM TO FUNCTIONAL HYPOPARATHYROIDISM

    May 1, 2019, 00:00

  • PCN277 SYSTEMATIC LITERATURE REVIEW OF UTILITY STUDIES IN PATIENTS WITH ADVANCED OR METASTATIC HEPATOCELLULAR CANCER

    May 1, 2019, 00:00

  • PDG41 TRENDS IN PRESCRIBED INPATIENT-SURGERY OPIOID USE AND EXPENSES IN THE U.S. USING 2011-2015 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2019, 00:00

  • PGI16 MAJOR CAUSES OF MORTALITY AMONG HOSPITALIZED DECOMPENSATED CIRRHOSIS PATIENTS: IMPLICATIONS FOR DISEASE MANAGEMENT

    May 1, 2019, 00:00

  • PIN7 A NETWORK META-ANALYSIS OF THE EFFICACY AND SAFETY OF BALOXAVIR MARBOXIL VERSUS NEURAMINIDASE INHIBITORS IN THE TREATMENT OF INFLUENZA VIRUS INFECTION IN HIGH-RISK PATIENTS

    May 1, 2019, 00:00

  • PNS137 ARE MEDICAL DIRECTORS' AND PHARMACY DIRECTORS' ATTITUDES DIFFERENT TOWARDS PROACTIVE HCEI AND PIE?

    May 1, 2019, 00:00

  • PDG70 SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER (IR) IN RHEUMATOID ARTHRITIS (RA) PATIENTS

    May 1, 2019, 00:00

  • PMS13 ASSOCIATION OF OPIOID ANALGESIC USE ON EMERGENCY DEPARTMENT LENGTH OF STAY AMONG LOW BACK PAIN PATIENTS: A UNITED STATES NATIONAL ANALYSIS

    May 1, 2019, 00:00

  • PMU78 METHODOLOGICAL ISSUES IN THEORY AND PRACTICE: NICE SCIENTIFIC ADVICE EXPERIENCE WITH ADVANCED THERAPY MEDICINAL PRODUCTS

    May 1, 2019, 00:00

  • PMU97 COVERAGE AND REVIEWS OF MEDICAL DEVICES, LABORATORY, AND DIAGNOSTIC TESTING BY U.S. HEALTH PLANS

    May 1, 2019, 00:00

  • PCN296 DEVELOPMENT OF SCIENTIFIC GUIDELINES FOR USE OF THE EORTC ITEM LIBRARY IN CANCER CLINICAL TRIALS

    May 1, 2019, 00:00

  • PMU22 ECONOMIC ANALYSIS OF USING COURIER SYSTEM ALONE COMPARED WITH A COMBINATION OF BACTEC MACHINES AND COURIER SYSTEM TO OBTAIN BLOOD SAMPLE RESULTS AT LOWER FACILITIES: A CASE OF THE EID PROJECT AT THE INFECTIOUS DISEASES INSTITUTE IN UG ...

    May 1, 2019, 00:00

  • PIN86 PATIENT- AND PROVIDER-LEVEL CHARACTERISTICS AND OUTCOMES ASSOCIATED WITH INAPPROPRIATE ANTIBIOTIC PRESCRIBING IN UNCOMPLICATED ACUTE ADULT BRONCHITIS IN THE OUTPATIENT SETTING

    May 1, 2019, 00:00

  • PIN54 ANALYSIS OF VACCINE ADVERSE EVENTS IN PREGNANT WOMEN IN THE US (2014-2018)

    May 1, 2019, 00:00

  • PMU63 RETROSPECTIVE ANALYSIS OF CHARACTERISTICS AND HEALTH RESOURCES UTILIZATION (HRU) OF MULTI-CONSULTANT PATIENTS IN AN INSURER

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Technology Assessment

    May 1, 2019, 00:00

  • PNS267 WINNING BEYOND THE REGULATOR. COMPARING THE VALUE OF DIFFERENT DATA TYPES FROM PAYER AND CLINICIAN PERSPECTIVES TO SUPPORT PRESCRIBING AND REIMBURSEMENT

    May 1, 2019, 00:00

  • PIH41 VARIATION IN POLYCYSTIC OVARY SYNDROME PATIENT CHARACTERISTICS BY BODY MASS INDEX: A REAL-WORLD ANALYSIS USING A CLAIMS AND ELECTRONIC HEALTH RECORD LINKED DATABASE

    May 1, 2019, 00:00

  • PCV38 A PHARMACOECONOMIC EVALUATION ON IRBESARTAN AND LEVOAMLODIPINE IN STROKE AND MYOCARDIAL INFARCTION PREVENTION AMONG HYPERTENSION PATIENTS IN CHINA

    May 1, 2019, 00:00

  • PMD43 PRE-OPERATIVE PREDICTORS OF POST-OPERATIVE PAIN RELIEF: PAIN SCORE MODELING FOLLOWING TOTAL KNEE ARTHROPLASTY

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Patient-Centered Research

    May 1, 2019, 00:00

  • PCN299 COST TREND ANALYSIS OF BREAST CANCER DRUGS IN LEBANON USING A PRIVATE PAYER DATA SET

    May 1, 2019, 00:00

  • PMU4 ANALISIS OF REAL WORLD EVIDANCE OF PERIODONTAL DISEASES IN PATIENTS WITH CHRONIC RHEUMATIC HEART DISEASE (CRHD) IN UKRAINE

    May 1, 2019, 00:00

  • PCN235 THE ROLE OF CLINICAL EVIDENCE SUBMITTED BY MANUFACTURERS TOWARDS ACCELERATED ACCESS APPROVAL; EVIDENCE FROM SEVEN COUNTRIES

    May 1, 2019, 00:00

  • PMS52 REAL-WORLD OUTCOMES AND COST OF MANAGEMENT OF OSTEOPOROTIC FRACTURES IN ONTARIO, CANADA

    May 1, 2019, 00:00

  • PDB126 COMPARATIVE HEALTHCARE COSTS AND MEDICATION BURDEN IN REAL-WORLD PATIENTS AUGMENTING METFORMIN MONOTHERAPY WITH EMPAGLIFLOZIN FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY

    May 1, 2019, 00:00

  • PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • PCN267 PATIENT SUPPORT PROGRAMS BECOMING INCREASINGLY PATIENT-CENTRIC WITHIN COMPETITIVE IMMUNO-ONOLOGY LANDSCAPE

    May 1, 2019, 00:00

  • PIT2 HOSPITAL LENGTH OF STAY, COMPLICATIONS, AND HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH OPEN REDUCTION INTERNAL FIXATION FOR HUMERUS FRACTURES

    May 1, 2019, 00:00

  • PIH57 KNOWLEDEGES AND EXPERIENCES OF PREGNANT WOMEN ON PRENATAL CARE PROGRAMS OF A SUBSIDIZED HEALTH CARE COMPANY FROM THE CARIBBEAN REGION OF COLOMBIA: A QUALITATIVE ANALYSIS

    May 1, 2019, 00:00

  • PND32 EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE

    May 1, 2019, 00:00

  • PNS262 GLOBAL TRENDS IN REGULATORY LEGISLATION FOR POST MARKETING SURVEILLANCE (PMS) REAL-WORLD EVIDENCE (RWE) STUDIES AND THE SECONDARY USE OF HEALTH DATA IN PMS STUDIES.

    May 1, 2019, 00:00

  • PND53 TREATMENT PATTERNS AND PROGNOSIS OF PATIENTS WITH AN INCIDENT DRUG-INDUCED PARKINSONISM

    May 1, 2019, 00:00

  • PND9 EVENT-FREE SURVIVAL AND MOTOR MILESTONE ACHIEVEMENT FOLLOWING AVXS-101 AND NUSINERSEN INTERVENTIONS CONTRASTED TO NATURAL HISTORY FOR TYPE I SPINAL MUSCULAR ATROPHY PATIENTS

    May 1, 2019, 00:00

  • PCV23 HEALTHCARE RESOURCE USE AND COSTS FOLLOWING CATHETER ABLATION IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) PATIENTS AGE 65

    May 1, 2019, 00:00

  • PMU68 BCBSLA EVALUATION OF A NURSE FOCUSED DISEASE MANAGEMENT PROGRAM IN LOUISIANA

    May 1, 2019, 00:00

  • PIH34 IMPACT OF ENDOMETRIOSIS DIAGNOSTIC DELAYS ON HEALTHCARE COSTS: A RETROSPECTIVE COHORT ANALYSIS

    May 1, 2019, 00:00

  • PND28 A BUDGET IMPACT ANALYSIS OF CENOBAMATE FOR THE TREATMENT OF REFRACTORY PARTIAL-ONSET EPILEPSY

    May 1, 2019, 00:00

  • PND55 SOCIETAL BURDEN OF MULTIPLE SCLEROSIS IN THE BRAZILIAN SOCIAL SECURITY SYSTEM

    May 1, 2019, 00:00

  • PMS23 BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN THE TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS IN QINGDAO, CHINA

    May 1, 2019, 00:00

  • PND23 SYSTEMATIC LITERATURE REVIEW OF ECONOMIC AND STATISTICAL MODELS OF AGITATION IN NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

    May 1, 2019, 00:00

  • Individual's Health - Health Technology Assessment

    May 1, 2019, 00:00

  • PND89 PERSISTENCE TO ORAL AND INJECTABLE MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES

    May 1, 2019, 00:00

  • PDG63 VARIATION OF PHARMACOTHERAPIES FOR OPIOID USE DISORDER ACROSS STATE MEDICAID PROGRAMS

    May 1, 2019, 00:00

  • PMH28 THE INCREASING RATE OF CHILDHOOD MENTAL ILLNESSES AND ASSOCIATED HEALTHCARE COSTS IN THE UNITED STATES: TRENDS OVER THE PAST DECADE

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Clinical Outcomes

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • Multiple Diseases - Clinical Outcomes

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS150 DISABILITY AS DEFINED BY MARKET ACCESS AND HEALTH ECONOMICS AND OUTCOMES RESEARCH PROFESSIONALS: MIXED METHODS.

    May 1, 2019, 00:00

  • PDB128 REDUCED HEALTHCARE UTILIZATION IN PATIENTS USING EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY

    May 1, 2019, 00:00

  • Medical Devices - Real World Data Information Systems

    May 1, 2019, 00:00

  • PMS24 NATIONWIDE, REAL-WORLD HEALTH INSURANCE TREATMENT COST OF SCOLIOSIS IN HUNGARY: A COST OF ILLNESS STUDY

    May 1, 2019, 00:00

  • Abstracts Disclaimer

    May 1, 2019, 00:00

  • PIN44 A MODEL TO EVALUATE THE IMPACT OF HOSPITAL-BASED INTERVENTIONS TARGETING FALSE-POSITIVE BLOOD CULTURES ON ECONOMIC AND CLINICAL OUTCOMES

    May 1, 2019, 00:00

  • PMS48 A LANDSCAPE ASSESSMENT OF STAND-ALONE PATIENT-REPORTED OUTCOME (PRO) MEASURES USED IN CLINICAL TRIALS FOR RHEUMATOID ARTHRITIS (RA)

    May 1, 2019, 00:00

  • PROMIS Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains

    May 1, 2019, 00:00

  • PMS28 QUALITY OF LIFE AND THE RELATIONSHIP WITH FAMILY INCOME IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2019, 00:00

  • PNS186 PERCEPTIONS AMONG COMMUNITY ONCOLOGISTS AND RHEUMATOLOGISTS ON DIRECT TO CONSUMER ADVERTISING (DTCA) IN HEALTHCARE

    May 1, 2019, 00:00

  • PMU102 MECHANISMS OF ENGAGEMENT IN PRESCRIPTION MEDICATION-RELATED DECISION MAKING: INFLUENCES OF EXPOSURE TO DIRECT-TO-CONSUMER ADVERTISING (DTCA)

    May 1, 2019, 00:00

  • PIH60 COMPARATIVE EFFICACY AND SAFETY OF PHOSPHODIESTERASE 5 INHIBITORS FOR ERECTILE DYSFUNCTION IN MEN WITH COMORBIDITIES: SYSTEMATIC REVIEW WITH NETWORK META-ANALYSIS

    May 1, 2019, 00:00

  • PMU67 INNOVATIVE APPROACHES TO DISEASE MANAGEMENT: BCBSLA'S ZERO DOLLAR CO-PAY PROGRAM FOR MEMBERS WITH CHRONIC DISEASES

    May 1, 2019, 00:00

  • PIN9 CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US

    May 1, 2019, 00:00

  • PMH2 PREDICTORS OF TREATMENT RESISTANT DEPRESSION AMONG ADULTS WITH CHRONIC NON-CANCER PAIN CONDITIONS: A MACHINE LEARNING APPROACH

    May 1, 2019, 00:00

  • PMD48 IMPACT OF SURGICEL ON SURGICAL OUTCOMES AND HOSPITAL COSTS ASSOCIATED WITH LUMBAR SURGERY IN A CHINESE TIER III TERTIARY CARE HOSPITAL

    May 1, 2019, 00:00

  • PCV39 RADIOFREQUENCY CATHETER ABLATION WITH WARFARIN VERSUS ANTIARRHYTHMIC DRUGS WITH NEW ORAL ANTICOAGULANTS FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION IN CHINA: A COST- EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PIN46 VAX-THE-NATION: A BUDGET IMPACT ANALYSIS OF INCREASED MEASLES, MUMPS AND RUBELLA VACCINATION UPTAKE IN THE US

    May 1, 2019, 00:00

  • PCV74 COST REDUCTION AFTER THE INDUCTION OF THE RESIDENT ENLIGHTMENT BASED ON MEDICAL CHECKUP IN A JAPANESE RURAL AREA

    May 1, 2019, 00:00

  • PNS16 EVALUATION OF THE MULTICRITERIA METHODOLOGY FOR THE USE IN EVALUATION OF HEALTH TECHNOLOGIES. ADVANTAGES AND DISADVANTAGES OF THE METHOD

    May 1, 2019, 00:00

  • PNS124 FEASIBILITY OF MULTI-INDICATION PRICING: A TARGETED REVIEW OF THE INTERNATIONAL LITERATURE

    May 1, 2019, 00:00

  • NO Specific Disease - Health Policy Regulatory

    May 1, 2019, 00:00

  • PMS19 POTENTIAL COST-SAVINGS DUE TO THE APPLICATION OF A CENTER OF EXCELLENCE CARE MODEL IN RHEUMATOID ARTHRITIS IN COLOMBIA

    May 1, 2019, 00:00

  • PNS27 RISK-BENEFIT ASSESSMENT USING THE LIKELIHOOD HELPED OR HARMED RATIO: SIMILARITIES AND DIFFERENCES WITH INCREMENTAL COST-EFFECTIVENESS RATIOS

    May 1, 2019, 00:00

  • PCN304 CARDIAC MONITORING AMONG CHEMOTHERAPY,TARGETED THERAPY AND RADIATION THERAPY TREATED BREAST CANCER PATIENTS

    May 1, 2019, 00:00

  • PIH29 MODELING THE TOTAL AND NET COST OF DEMENTIA IN THE UNITED STATES

    May 1, 2019, 00:00

  • Individual's Health - Methodological Statistical Research

    May 1, 2019, 00:00

  • PNS10 INNOVATIVE PHARMACEUTICAL PRICING AND REIMBURSEMENT SCHEMES IN THE US, A CAUTIONARY TALES FROM ABROAD

    May 1, 2019, 00:00

  • PNS215 A COMPARISON OF R PACKAGES FOR PREDICTION AND SIMULATION OF MULTI-STATE MODELS FOR COST-EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PNS207 HOW TO CAPTURE THE IMPACT OF SELECTION BIASES IN CLINICAL PRACTICE ON THE AVERAGE EFFICACY OF TREATMENT

    May 1, 2019, 00:00

  • PNS81 STATUS OF EXPANDED ACCESS PROGRAM (EAP) REGISTRATION INTO CLINICALTRIALS.GOV FOLLOWING 21ST CENTURY CURES ACT

    May 1, 2019, 00:00

  • PCN293 REAL-WORLD PRODUCTIVITY, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND QUALITY OF LIFE (QOL) IN PATIENTS RECEIVING FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (GC) IN CANADA AND EUROPE

    May 1, 2019, 00:00

  • PDG6 HEALTHCARE RESOURCE UTILIZATION, COST, AND TREATMENT PERSISTENCE AMONG TREATMENT-NAIVE PAH PATIENTS INITIATING MONOTHERAPY VS. COMBINATION THERAPY

    May 1, 2019, 00:00

  • PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE

    May 1, 2019, 00:00

  • PDG54 UNDERSTANDING TEXAS COMMUNITY PHARMACISTS' ATTITUDES TOWARD MANDATED PDMP USE AND SEVEN DAY PRESCRIBING LIMITS ON OPIOID PRESCRIPTIONS FOR ACUTE NON-CANCER PAIN

    May 1, 2019, 00:00

  • PMH59 WHAT MOTIVATES PEOPLE WITH SUBSTANCE USE DISORDERS TO PURSUE TREATMENT? A PATIENT-CENTERED APPROACH TO UNDERSTANDING PATIENT EXPERIENCES AND PATIENT-PROVIDER INTERACTIONS

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    May 1, 2019, 00:00

  • PCV50 REAL-WORLD ECONOMIC OUTCOMES COMPARISON BETWEEN THERMOCOOL SMARTTOUCH® SF CATHETER AND THERMOCOOL SMARTTOUCH® CATHETER AMONG PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING ABLATION IN AN OUTPATIENT SETTING: RESULTS FROM MULTI-HOSPITAL D ...

    May 1, 2019, 00:00

  • PMS18 COST-EFFECTIVENESS OF TOFACITINIB FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN CHINA

    May 1, 2019, 00:00

  • Infectious Diseases - Health Policy Regulatory

    May 1, 2019, 00:00

  • PMU3 PUBLICLY DISCLOSED OUTCOMES-BASED CONTRACTS IN UNITED STATES

    May 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS ANALYSIS OF TEGADERM CHLORHEXIDINE GLUCONATE(CHG) DRESSING VERSUS STANDARD DRESSING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN CHINESE INTENSIVE CARE UNITS

    May 1, 2019, 00:00

  • NO Specific Disease - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PNS84 EAMS VS. ATU: COMPARING EARLY ACCESS TO UNLICENSED MEDICINES IN UK AND FRANCE

    May 1, 2019, 00:00

  • Back to the Future With Value in Health

    May 1, 2019, 00:00

  • NO Specific Disease - Economic Evaluation

    May 1, 2019, 00:00

  • PNS90 POLICY CHANGES AND IMPACT ON PRICING AND ACCESS OF DRUGS IN US

    May 1, 2019, 00:00

  • PDB118 EVIDENCE MAPPING OF INSULIN MANAGEMENT DRIVERS TO ECONOMIC AND CLINICAL OUTCOMES

    May 1, 2019, 00:00

  • PMU12 SCALABLE DECISION-ANALYTIC MODELLING WITH INFLUENCE DIAGRAMS

    May 1, 2019, 00:00

  • Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery

    May 1, 2019, 00:00

  • PNS251 CULTURAL ADAPTATION AND VALIDATION OF THE KOREAN VERSION OF IMTA PRODUCTIVITY COST QUESTIONNAIRE (IPCQ)

    May 1, 2019, 00:00

  • PNS42 R NICE LAGGING BEHIND THE WORLD?

    May 1, 2019, 00:00

  • PIH47 HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA AMONG EARLY PRETERM NEWBORNS: PREVALENCE, TREATMENT PATTERNS AND BURDEN OF ILLNESS

    May 1, 2019, 00:00

  • PIN71 VACCINATION AND POTENTIAL MISSED OPPORTUNITIES AMONG ADULTS IN THE UNITED STATES DURING THE AFFORDABLE CARE ACT ERA

    May 1, 2019, 00:00

  • PCV102 HEALTH RELATED QUALITY OF LIFE OF STROKE SURVIVORS COMPARED TO NON-STROKE INDIVIDUALS AMONG AFRICAN AMERICANS IN THE UNITED STATES: A NATIONALLY REPRESENTATIVE PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2019, 00:00

  • PNS201 MEASUREMENT COMPARABILITY OF ELECTRONIC AND PAPER ADMINISTERED VISUAL ANALOGUE SCALES: A REVIEW OF PUBLISHED STUDIES

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Clinical Outcomes

    May 1, 2019, 00:00

  • PCN258 IMPROVING THE ACCURACY OF MEASURING DURATION OF THERAPY BY IDENTIFYING PATIENTS WHO REMAIN ON-TREATMENT IN A REAL-WORLD DATABASE

    May 1, 2019, 00:00

  • PNS123 RISK ADJUSTING MEDICARE ADVANTAGE PLAN PERFORMANCE MEASURES FOR SOCIAL DETERMINANTS OF HEALTH: ARE DUAL ELIGIBILITY AND DISABILITY STATUS ENOUGH?

    May 1, 2019, 00:00

  • PND17 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH PARKINSON'S DISEASE: A LONGITUDINAL STUDY

    May 1, 2019, 00:00

  • PDG5 COMMONLY REPORTED ADVERSE EVENTS ASSOCIATED WITH ANTICOAGULANTS USING FDA ADVERSE EVENT REPORTING SYSTEM DATABASE 2012-2018

    May 1, 2019, 00:00

  • Multiple Diseases - Real World Data Information Systems

    May 1, 2019, 00:00

  • Neurological Disorders - Patient-Centered Research

    May 1, 2019, 00:00

  • PIH12 BURDEN OF ADVERSE DRUG EVENTS (ADE) DURING HOSPITALIZATION IN OLDER ADULTS- A CROSS SECTIONAL ANALYSIS USING NATIONWIDE READMISSION DATABASE

    May 1, 2019, 00:00

  • Drugs Generics - Patient-Centered Research

    May 1, 2019, 00:00

  • PDB25 THE EFFECT OF MEDICATION NON-ADHERENCE ON HOSPITALIZATION COSTS AMONG MEDICARE ENROLLEES WITH DRUG COVERAGE THROUGH A PHARMACY ASSISTANCE PROGRAM

    May 1, 2019, 00:00

  • PCN300 EVALUATION OF OVERALL SURVIVAL ASSOCIATED WITH CHANGE IN DOSING OF BORTEZOMIB, MELPHALAN, AND PREDNISONE REGIMEN IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A REAL-WORLD STUDY

    May 1, 2019, 00:00

  • PMS9 EVALUATING THE PERFORMANCE OF THREE ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) MEASURES IN TOTAL KNEE ARTHROPLASTY (TKA)

    May 1, 2019, 00:00

  • PNS139 EVALUATION OF HUNGARIAN ONE-DAY SURGERY IN LIGHT OF DIAGNOSIS RELATED GROUPS’ VALUE

    May 1, 2019, 00:00

  • PMD9 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICE COMPARED TO USUAL CARE FOR SEVERE OBSTRUCTIVE SLEEP APNEA: A COST-EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PMS10 TREATMENT-RELATED LIVER INJURIES AMONG PATIENTS WITH SPONDYLOARTHRITIDES (SPA)

    May 1, 2019, 00:00

  • PCV13 RISK OF CARDIOVASCULAR OUTCOMES AND ANTIHYPERTENSIVE TRIPLE COMBINATION THERAPY AMONG PATIENTS ENROLLED IN A MEDICARE ADVANTAGE PLAN (MAP)

    May 1, 2019, 00:00

  • Drug Related Public Health Studies

    May 1, 2019, 00:00

  • PIN98 STUDY ON PREFERENCE OF VACCINATION SCHEME SELECTION FOR CERVICAL CANCER

    May 1, 2019, 00:00

  • PMH21 THE ECONOMIC BURDEN OF ILLNESS OF SCHIZOPHRENIA IN THE US

    May 1, 2019, 00:00

  • Mental Health - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PCN290 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS (ALLO-HSCT) ARE ASSOCIATED WITH POOR QUALITY OF LIFE (QOL) AND ECONOMIC BURDEN DUE TO GRAFT-VERSUS-HOST DISEASE (GVHD) COMPLICATIONS: RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR) ...

    May 1, 2019, 00:00

  • PCV83 THE BENEFITS OF DEFERRED PAYMENT IN CONGESTIVE HEART FAILURE GENE THERAPY

    May 1, 2019, 00:00

  • PND22 THE BURDEN OF NON-MOTOR SYMPTOMS ON HEALTHCARE RESOURCE UTILISATION AMONG PATIENTS WITH PARKINSON'S DISEASE: A NEUROLOGIST/PATIENT REAL-WORLD ASSESSMENT IN THE US

    May 1, 2019, 00:00

  • PMS20 COMPARATIVE EFFECTIVENESS OF NOVEL VERSUS TRADITIONAL RHEUMATOID ARTHRITIS THERAPIES - A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • Individual's Health - Clinical Outcomes

    May 1, 2019, 00:00

  • PIN58 PREVALENCE OF PARASITE INTESTINAL INFECTIONS IN A RURAL COMMUNITY OF THE CARIBBEAN NORTH OF COLOMBIA

    May 1, 2019, 00:00

  • PCV62 ASSESSING THE RISK FACTORS OF HEART FAILURE AMONG PATIENTS IN THE DEPARTMENT OF DEFENSE POPULATION

    May 1, 2019, 00:00

  • PND42 COST-EFFECTIVENESS ANALYSIS OF ERENUMAB VERSUS TOPIRAMATE FOR PATIENTS WITH CHRONIC MIGRAINES TO IDENTIFY THE COST-EFFECTIVE PRICE THRESHOLD IN GREECE

    May 1, 2019, 00:00

  • PIN40 POST-OPERATIVE ANTIBIOTIC COST PROJECT: DISCONTINUATION OF ANTIMICROBIAL PROPHYLAXIS AFTER SURGICAL INCISION CLOSURE

    May 1, 2019, 00:00

  • PMD26 MEDICAL RESOURCE UTILIZATION AND COSTS FOR INTRAOPERATIVE PERIPROSTHETIC HIP FRACTURES DURING TOTAL HIP ARTHROPLASTY IN THE MEDICARE POPULATION: A DIRECT AND PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2019, 00:00

  • NO Specific Disease - Clinical Outcomes

    May 1, 2019, 00:00

  • PMD13 ECONOMICS EVALUATION OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR LIVER CANCER: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • Infectious Diseases - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PH2 DUAL-TRAJECTORIES OF OPIOID AND GABAPENTINOID USE AND RISK OF SUBSEQUENT DRUG OVERDOSE AMONG UNITED STATES MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • PNS156 THE EFFECTIVENESS OF PERSONALISATION ON HEALTH OUTCOMES OF OLDER PEOPLE: A SYSTEMATIC REVIEW.

    May 1, 2019, 00:00

  • PNS208 A TARGETED LITERATURE REVIEW COMPARING MACHINE LEARNING ALGORITHMS TO STANDARD REGRESSION MODELS IN REAL WORLD EVIDENCE

    May 1, 2019, 00:00

  • PDB43 SYSTEMATIC REVIEW OF THE COST EFFECTIVENESS ANALYSIS OF LIFESTYLE INTERVENTION VERSUS STANDARD CARE FOR PREVENTION OF TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PDB52 LITERATURE REVIEW OF ECONOMIC AND CLINICAL OUTCOMES ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)

    May 1, 2019, 00:00

  • Drugs Public Health

    May 1, 2019, 00:00

  • PNS13 DYNAMIC APPROACHES TO VISUALIZING HEOR DATA: TELLING A COMPLICATED NMA STORY, MORE SIMPLY

    May 1, 2019, 00:00

  • Individual's Health - Patient-Centered Research

    May 1, 2019, 00:00

  • PCN251 ESTIMATING QUALITY-ADJUSTED LIFE YEARS (QALYS) THROUGH QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (QTWIST) IN RCTS: AN ALTERNATIVE TO ECONOMIC MODELLING

    May 1, 2019, 00:00

  • PND54 BURDEN OF DISEASE ASSOCIATED WITH DEMENTIA-RELATED PSYCHOSIS USING A NATIONAL LONG-TERM CARE US DATABASE

    May 1, 2019, 00:00

  • PDG42 OPIOID USE FOR TREATMENT OF ACUTE PAIN AMONG CHILDREN AND ADOLESCENTS ENROLLED IN THE MISSISSIPPI MEDICAID PROGRAM

    May 1, 2019, 00:00

  • PDB102 MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES

    May 1, 2019, 00:00

  • PDB20 THE IMPACT OF ANXIETY AND DEPRESSION IN TYPE 1 DIABETES MELLITUS (T1DM) PATIENTS WHO EXPERIENCE SEVERE HYPOGLYCEMIC EPISODES (HYPOS)

    May 1, 2019, 00:00

  • PCN265 BREAST CANCER PATIENT PREFERENCE AND WILLINGNESS TO PAY FOR GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSF)

    May 1, 2019, 00:00

  • PNS14 BIOSIMILARS: GROWTH AND OPPORTUNITIES

    May 1, 2019, 00:00

  • PH3 A RETROSPECTIVE DATABASE ANALYSIS OF SHORT-ACTING AND LONG-ACTING OPIOID USE IN WOMEN WITH ENDOMETRIOSIS: I-DEMOGRAPHIC CHARACTERISTICS AND PREVALENCE OF USE

    May 1, 2019, 00:00

  • PDG68 TO EXAMINE DIFFERENCES IN OPIOID PRESCRIBING AND ADJUNCT PAIN SERVICES BY CONCENTRATION OF OPIOID PRESCRIBING PATTERNS IN VETERANS' ADMINISTRATION MEDICAL CENTERS IN THE U.S.

    May 1, 2019, 00:00

  • PCN316 BRCA TESTING UTILIZATION AND REIMBURSEMENT TRENDS IN THE UNITED STATES FROM 2007-2016: A DESCRIPTIVE ANALYSIS

    May 1, 2019, 00:00

  • PIH70 EXPLORING VARIABILITY IN PATIENT-REPORTED PAIN AND TREATMENT EFFICACY IN PATIENTS WITH ENDOMETRIOSIS

    May 1, 2019, 00:00

  • PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT DISCONTINUATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREATMENT IN U.S. HOSPITALS: 2012-2015

    May 1, 2019, 00:00

  • Neurological Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PGI10 COST-EFFECTIVENESS ANALYSIS OF RADIO-FREQUENCY ABLATION IN PATIENTS WITH BARRETT’S ESOPHAGUS AND HIGH GRADE DYSPLASIA IN ITALY

    May 1, 2019, 00:00

  • PCN273 A SYSTEMATIC LITERATURE REVIEW OF THE HEALTH-RELATED QUALITY OF LIFE BURDEN ASSOCIATED WITH NON-MUSCLE INVASIVE BLADDER CANCER AND RADICAL CYSTECTOMY

    May 1, 2019, 00:00

  • PCV17 ASSOCIATION BETWEEN EXPOSURE/ADHERENCE TO A CARDIOVASCULAR RISK MANAGEMENT PROGRAM AND THE INCIDENCE AND MORTALITY OF CARDIOVASCULAR EVENTS IN THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2019, 00:00

  • PND70 ASSESSMENT OF MIGRAINE PROGRESSION AND PREDICTORS OF PROGRESSION USING A CLAIMS- AND ELECTRONIC HEALTH RECORD-INTEGRATED DATABASE

    May 1, 2019, 00:00

  • PCV94 PRESCRIBING PATTERNS FOR PATIENTS WITH HEART FAILURE AT DISCHARGE IN A TERTIARY HOSPITAL, IN RIYADH

    May 1, 2019, 00:00

  • PDG35 COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE RIVAROXABAN PLUS ASPIRIN FOR THE PATIENTS WITH STABLE CARDIOVASCULAR DISEASE IN TAIWAN SETTING

    May 1, 2019, 00:00

  • PNS206 CAN WE IMPROVE THE ESTIMATION OF CENSORED COST DATA USING RANDOM FORESTS?

    May 1, 2019, 00:00

  • PNS248 THE INVOLVEMENT OF PATIENTS IN THE REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS

    May 1, 2019, 00:00

  • PCV75 MULTI-CENTER STUDY ON THE IMPACT OF CYTOCHROME P450 3A4 AND P-GLYCOPROTEIN INTERACTING MEDICATIONS ON BLEEDING AND THROMBOEMBOLISM RISK IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS MANAGED ON RIVAROXABAN THERAPY

    May 1, 2019, 00:00

  • Mental Health - Economic Evaluation

    May 1, 2019, 00:00

  • PMD17 ESTIMATION OF US HOSPITAL COST SAVINGS ASSOCIATED WITH HYPOTENSION REDUCTION FOR MEAN ARTERIAL PRESSURE (MAP) ABOVE 65MMHG IN SEPTIC INTENSIVE CARE UNIT PATIENTS

    May 1, 2019, 00:00

  • PMH52 ARE PHYSICIANS COMPLYING WITH AAP-2011 TREATMENT GUIDELINES FOR ADHD? A COMPARATIVE ANALYSIS OF SPECIALIST VS. NONSPECIALIST PRESCRIBING AND USE OF PSYCHOTHERAPY IN CHILDREN

    May 1, 2019, 00:00

  • PDG52 A COMPARATIVE ANALYSIS ON THE RISKS OF USING OTC PRODUCTS COMPARED TO PRESCRIPTION DRUGS

    May 1, 2019, 00:00

  • PCV86 THE RELATIONSHIP BETWEEN SIGNATURE TIME AND FUNCTIONAL HEALTH LITERACY IN AN UNDERSERVED URBAN POPULATION

    May 1, 2019, 00:00

  • PPM8 A MACHINE LEARNING MODEL FOR CANCER BIOMARKER IDENTIFICATION IN ELECTRONIC HEALTH RECORDS

    May 1, 2019, 00:00

  • PNS65 DESCRIPTIVE EPIDEMIOLOGY OF SMOKING STATUS IN A REAL WORLD SAMPLE OF ADULTS IN THE UNITED STATES: 2010 - 2017

    May 1, 2019, 00:00

  • PNS78 DIFFERENCES BETWEEN ENROLLEES OF INDIVIDUAL VERSUS SMALL GROUP OFF-EXCHANGE HEALTH PLANS UNDER THE AFFORDABLE CARE ACT

    May 1, 2019, 00:00

  • PNS94 CURRENT UTILIZATION AND PERCEPTIONS OF VALUE ASSESSMENT FRAMEWORKS BY PHARMACY AND THERAPEUTICS COMMITTEES IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PDB16 TRENDS IN THE QUALITY OF DIABETES CARE IN THE UNITED STATES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES), 1999 TO 2016

    May 1, 2019, 00:00

  • PNS157 IDENTIFICATION AND COST OF DIAGNOSTIC TESTS FOR INFECTION IN DIABETIC FOOT ULCERS, PRESSURE ULCERS, AND VENOUS LEG ULCERS

    May 1, 2019, 00:00

  • PCN246 A SYSTEMATIC APPROACH FOR QUANTIFYING HETEROGENEITY WITHIN CLINICAL TRIAL POPULATIONS

    May 1, 2019, 00:00

  • PCV53 THERAPEUTIC INTENSITY ALGORITHM IS ASSOCIATED WITH ANNUAL EXPENDITURES IN MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTS WITH AND WITHOUT MITRAL REGURGITATION

    May 1, 2019, 00:00

  • NO Specific Disease - Real World Data Information Systems

    May 1, 2019, 00:00

  • PCV89 ANALYSIS OF THE LIST OF MEDICINES FOR TREATMENT OF HYPERTENSION IN PREGNANCY IN UKRAINE

    May 1, 2019, 00:00

  • PNS224 AN ADMINISTRATIVE HEALTH DATA DRIVEN SCORE FOR A HEALTH INSURANCE COMPANY: A NEW METHODOLOGICAL APPROACH

    May 1, 2019, 00:00

  • PCV44 COST-EFFECTIVENESS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF REAL WORLD DATA

    May 1, 2019, 00:00

  • PIT6 COST-EFFECTIVENESS OF PHENYTOIN VERSUS LEVETIRACETAM FOR EARLY SEIZURE PHARMACOPROPHYLAXIS AFTER TRAUMATIC BRAIN INJURY: TRIAL-BASED ANALYSIS IN A PATIENT PERSPECTIVE

    May 1, 2019, 00:00

  • PGI21 OPTIMAL PATIENT SELECTION AND REFERRAL CARE PATHWAYS FOR ANTI-REFLUX SURGICAL PROCEDURES

    May 1, 2019, 00:00

  • PDG12 EFFECTS OF MEDICAID EXPANSION ON ADHERENCE TO ORAL HYPOGLYCEMIC MEDICATIONS IN LOW-INCOME POPULATIONS

    May 1, 2019, 00:00

  • PND12 CLINICAL EFFICACY OF VALBENAZINE AND DEUTETRABENAZINE FOR THE TREATMENT OF TARDIVE DYSKINESIA: INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2019, 00:00

  • PIH55 NATIONAL PATTERNS OF EMERGENCY DEPARTMENT USE FOR WOMEN WITH ENDOMETRIOSIS, 2006-2015

    May 1, 2019, 00:00

  • PDG69 NATIONWIDE TRENDS IN PRESCRIPTION OPIOID USE AMONG ADULTS: A PRE-PUBLIC HEALTH EMERGENCY PERSPECTIVE ON THE OPIOID CRISIS

    May 1, 2019, 00:00

  • PNS43 IDENTIFYING AND ASSESSING THE FEASIBILITY OF PROPOSED ALTERNATIVE APPROACHES TO QALY ESTIMATION WITHIN COST-EFFECTIVENESS MODELS USING A SYSTEMATIC LITERATURE REVIEW: AN UPDATED ANALYSIS

    May 1, 2019, 00:00

  • PNS86 INCREASE OF ONE-DAY SURGERY CASE NUMBERS IN LIGHT OF HEALTH CARE INSTITUTIONS – HUNGARIAN EXPERIENCES BETWEEN 2008-2017

    May 1, 2019, 00:00

  • PNS258 THE INCLUSION OF THE UTILITY VALUES FOR CARERS AND FAMILY MEMBERS IN HTAS: A CASE STUDY OF RECENT NICE APPRAISALS IN THE UK

    May 1, 2019, 00:00

  • PIN66 VACCINE PREGNANCY REGISTRIES: METHODS AND IMPACT ON FINDINGS

    May 1, 2019, 00:00

  • PIH9 UNMET NEED ASSOCIATED WITH AVAILABLE THERAPEUTIC OPTIONS FOR MANAGEMENT OF DYSPAREUNIA RELATED TO GENITOURINARY SYNDROME OF MENOPAUSE: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PCN295 PATIENT-CENTERED OUTCOMES IN ARIEL3, A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH RECURRENT OVARIAN CARCINOMA

    May 1, 2019, 00:00

  • PNS240 A COMPARISON OF METHODS FOR ANCHORING DCE-DERIVED LATENT UTILITIES ONTO THE QALY SCALE: EVIDENCE FROM SF-6D V2

    May 1, 2019, 00:00

  • Mental Health - Clinical Outcomes

    May 1, 2019, 00:00

  • PNS50 MODELING THE ECONOMIC VALUE OF MEDICATION SYNCHRONIZATION AMONG COMMERCIAL AND MEDICAID POPULATIONS

    May 1, 2019, 00:00

  • PDB97 IMPACT TO DIABETES QUALITY PERFORMANCE MEASURES IN AN OLDER ADULT POPULATION WHEN USING A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE FOR BASAL-BOLUS INSULIN THERAPY

    May 1, 2019, 00:00

  • PDG19 COST-EFFECTIVENESS OF INTRANASAL NALOXONE DISTRIBUTION TO HIGH RISK PRESCRIPTION OPIOID USERS

    May 1, 2019, 00:00

  • PDB30 COMPARABILITY OF RESULTS USING TWO ALTERNATIVE VERSIONS OF THE IQVIA CORE DIABETES MODEL

    May 1, 2019, 00:00

  • PNS256 HOW TO RESOLVE PROBLEMS EXPERIENCED WITH REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS WHEN PATIENTS ARE INVOLVED

    May 1, 2019, 00:00

  • PCN307 IMPACT OF EHR TECHNOLOGY UPDATES ON PATIENTS' ACCESS TO ONCOLOGY DRUGS

    May 1, 2019, 00:00

  • PMH57 ASSESSMENT OF HUMANISTIC BURDEN, A PATIENT REPORTED OUTCOMES STUDY OF MENTAL DISORDERS IN JAPAN AND CHINA

    May 1, 2019, 00:00

  • PMS33 EPIDEMIOLOGY AND ECONOMIC BURDEN OF TOTAL HIP ARTHROPLASTY IN JAPAN

    May 1, 2019, 00:00

  • PNS6 THE USE OF VARIABLE WILLINGNESS-TO-PAY THRESHOLDS IN HTA DECISION-MAKING TO REFLECT SOCIETAL VALUES FOR HEALTHCARE PROVISION

    May 1, 2019, 00:00

  • PCN256 CONTROL OF LEAD TIME BIAS IN HEALTH TECHNOLOGY ASSESSMENT: METHOD AND EXAMPLES

    May 1, 2019, 00:00

  • PDB68 DEMOGRAPHIC AND CLINICAL PROFILES OF PATIENTS WITH TYPE 2 DIABETES NEWLY INITIATING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS COMPARED TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS

    May 1, 2019, 00:00

  • PCV72 HEALTH BEHAVIORS AMONG MYOCARDIAL INFARCTION SURVIVORS IN THE UNITED STATES: A PROPENSITY SCORE MATCHED STUDY

    May 1, 2019, 00:00

  • Medical Devices - Medical Technologies

    May 1, 2019, 00:00

  • PNS63 MODELING REDUCTIONS IN ABSOLUTE CANCER MORTALITY FROM DIAGNOSING CANCERS BEFORE METASTASIS, 2006-2015

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Economic Evaluation

    May 1, 2019, 00:00

  • Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling

    May 1, 2019, 00:00

  • PMU49 CHANGES IN ANALGESIC PRESCRIBING AMONG TEXAS ADVANCED PRACTICE PROVIDERS AFTER RESCHEDULING OF HYDROCODONE COMBINATION PRODUCTS

    May 1, 2019, 00:00

  • PDB72 RESOURCES USE AND ECONOMIC IMPACT OF PATIENTS WITH GOUT: REAL WORD EVIDENCE

    May 1, 2019, 00:00

  • PCV7 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN THE REDUCTION OF PREMATURE MORTALITY ASSOCIATED TO CARDIOVASCULAR EVENTS IN THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2019, 00:00

  • PMU30 CHANGE IN THE PREVALENCE OF DEPRESSION AMONG PEOPLE WITH HYPERTENSION BETWEEN THE JNC 7 AND ACC/AHA 2017 GUIDELINES: US NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES), 2008-2016 COHORT

    May 1, 2019, 00:00

  • PIT9 EXAMINING THE REAL-WORLD HEALTHCARE COSTS OF TREATING CHRONIC WOUNDS

    May 1, 2019, 00:00

  • PNS200 METHODOLOGICAL VARIATIONS AMONG HEALTH STATE VALUATION STUDIES USING EQ-5D-5L: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PNS180 UNMET NEEDS EXIST IN PAYER COMMUNICATIONS - ARE DIGITAL SOLUTIONS THE ANSWER?

    May 1, 2019, 00:00

  • PNS189 A CAPACITY ASSESSMENT FOR A CLINICAL PHARMACY SERVICE OF A PUBLIC-SCHOOL HOSPITAL: A DISCRETE-EVENT SIMULATION CASE STUDY

    May 1, 2019, 00:00

  • PDG83 ATTITUDES AND INTENTION OF PHARMD STUDENTS TO USE STIMULANTS FOR ENHANCING ACADEMIC PERFORMANCE

    May 1, 2019, 00:00

  • PDG66 METFORMIN DOSAGE PATTERNS IN TYPE 2 DIABETES PATIENTS IN A REAL-WORLD HEALTHCARE SETTING IN THE UNITED STATES

    May 1, 2019, 00:00

  • PDG77 THE EMERGENCE OF THERAPEUTIC RADIOPHARMACEUTICALS. DO THE EXTRA COSTS OUTWEIGH THE GAINS?

    May 1, 2019, 00:00

  • PCN269 DETERMINATION OF HEALTH-RELATED QUALITY OF LIFE BY USING EQ-5D 3L IN CANCER PATIENTS IN SWAT, KHYBER PAKHTUNKHWA PAKISTAN

    May 1, 2019, 00:00

  • PIH14 IMPROVING DEMENTIA ECONOMICS THROUGH EARLIER COST-EFECTIVE ASSESSMENT

    May 1, 2019, 00:00

  • PNS173 EVALUATION OF THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) PUBLIC ENGAGEMENT PROCESS: STAKEHOLDER COMMENT ANALYSIS

    May 1, 2019, 00:00

  • PCV30 ESTIMATING HEALTH-STATE UTILITY IN PATIENTS WITH HEART FAILURE: MAPPING THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE TO SF-6D UTILITY SCORES

    May 1, 2019, 00:00

  • PNS198 DEVELOPMENT OF EARLY DECISION ANALYTICS (DA) PLATFORM TO SUPPORT RESEARCH AND DEVELOPMENT MILESTONES WITH ANTICIPATED REAL-WORLD VALUE

    May 1, 2019, 00:00

  • PCN247 PROGRESSION-FREE SURVIVAL (PFS) WITH DARATUMUMAB- BORTEZOMIB-MELPHALAN-PREDNISONE (D-VMP) COMBINATION THERAPY AND ALTERNATIVE TREATMENTS FOR PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA (MM) INELIGIBLE FOR STEM CELL TRANSPLANTATION ...

    May 1, 2019, 00:00

  • PCN234 DEVELOPMENT AND VALIDATION STUDY OF ARTIFICIAL INTELLIGENCE SUPPORTING SYSTEMATIC LITERATURE REVIEW FOR CONDUCTING COST-EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PMU34 BETA-BLOCKERS AND COGNITIVE IMPAIRMENT AMONG ADULTS WITH HYPERTENSION OR CARDIOVASCULAR DISEASES IN THE UNITES STATES

    May 1, 2019, 00:00

  • PNS246 EXPLORING THE PERFORMANCE OF USING DISCRETE CHOICE EXPERIMENTS FOR ELICITING HEALTH STATE UTILITIES IN CHINA: EVIDENCE FROM SF-6D V2

    May 1, 2019, 00:00

  • PNS20 A CONCEPTUAL PAPER ON DEVELOPING AND VALIDATING A NOVEL INDEX; DOCTOR'S SAFETY INDEX (DSI) THAT CAN AID HOSPITAL HEALTH POLICY TO TACKLE THE GROWING WORKPLACE VIOLENCE AGAINST DOCTORS.

    May 1, 2019, 00:00

  • PCV26 A COMPARISON OF THE COSTS OF ATRIAL FIBRILLATION ABLATION USING RADIOFREQUENCY CONTACT FORCE AND CRYOBALLOON TECHNOLOGIES IN THE UNITED STATES: AN ANALYSIS OF PROPENSITY SCORE MATCHED POPULATIONS

    May 1, 2019, 00:00

  • PCN283 HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH BARRETTS ESOPHAGUS AND CANCER

    May 1, 2019, 00:00

  • Infectious Diseases - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS166 CROSS-COUNTRY ICER EVOLUTION: WHAT DOES IT NOW MEAN TO BE COST-EFFECTIVE?

    May 1, 2019, 00:00

  • PNS176 ECONOMIC EVALUATION OF MEDICAL DEVICES: ARE THERE LESSONS TO BE LEARNT FROM EUROPE

    May 1, 2019, 00:00

  • PMU39 APPROACHES TO SAFETY REPORTING IN OBSERVATIONAL STUDIES

    May 1, 2019, 00:00

  • PNS254 A DESIGN THINKING APPROACH TO PATIENT SUPPORT PROGRAMS

    May 1, 2019, 00:00

  • PDG43 SAFETY EVALUATION OF ZOLEDRONIC ACID AND DENOSUMAB USING FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE 2012-2018

    May 1, 2019, 00:00

  • NO Specific Disease - Medical Technologies

    May 1, 2019, 00:00

  • PNS168 CHALLENGES IN THE DESIGN AND IMPLEMENTATION OF COVERAGE WITH DEVELOPMENT SCHEMES FOR MEDICAL DEVICES

    May 1, 2019, 00:00

  • PCV85 STRESS MANAGEMENT EDUCATION AND COUNSELING AMONG HYPERTENSIVE PATIENTS: AN ANALYSIS OF AMBULATORY CARE SURVEY DATA

    May 1, 2019, 00:00

  • PCV92 IMPROVING MEMBERS HYPERTENSION AT BLUE CROSS BLUE SHIELD OF LOUISIANA: THE EFFECTIVENESS OF OCHSNER'S DIGITAL MEDICINE HYPERTENSION (DMH) PROGRAM

    May 1, 2019, 00:00

  • Multiple Diseases - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PDB75 EVENT RATE OF HYPOGLYCEMIA AND PREVALENCE OF COMORBIDITIES IN PATIENTS WITH TYPE 2 DIABETES IN TIANJIN, CHINA

    May 1, 2019, 00:00

  • PDB100 PREDICTING HYPOPARATHYROIDISM DIAGNOSIS IN MEDICARE CLAIMS - EXPLORING THE UTILITY OF SEQUENCE ANALYSIS

    May 1, 2019, 00:00

  • PMD41 ECONOMIC IMPACT OF NOVEL DIGITAL THERAPEUTICS IN DIABETES, DYSLIPIDEMIA, AND HYPERTENSION

    May 1, 2019, 00:00

  • PIH63 THE UNDERSTANDING OF BLOOD CLOTTING DISEASES IN PREGNANT WOMEN AT AN INCREASED RISK

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PCV24 INCREMENTAL DIRECT HEALTHCARE EXPENDITURES OF VALVULAR HEART DISEASE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS3 RETHINKING THE IMPACT OF FORMULARY CHANGES ON PATIENT HEALTH OUTCOMES

    May 1, 2019, 00:00

  • PNS62 A DESCRIPTIVE STUDY OF POTENTIALLY AVOIDABLE HOSPITALIZATIONS AMONG DISABLED PATIENTS WITH DEPRESSION OR SLEEP DISORDERS

    May 1, 2019, 00:00

  • “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier

    May 1, 2019, 00:00

  • PND29 COST-EFFECTIVENESS OF MIROGABALIN FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN TAIWAN

    May 1, 2019, 00:00

  • PND10 SYSTEMATIC LITERATURE REVIEW OF OUTCOMES ASSOCIATED WITH SINGLE AND DUAL STENT-ASSISTED COIL EMBOLIZATION IN WIDE-NECKED BIFURCATION ANEURYSMS

    May 1, 2019, 00:00

  • PDB69 EFFECTIVENESS AND ADHERENCE OF LEVOTHYROXINE THERAPY

    May 1, 2019, 00:00

  • PMU31 ANALYSIS OF RISK FACTORS ASSOCIATED WITH INFECTION AND MORTALITY AMONG HOSPITALIZED LUNG CANCER PATIENTS

    May 1, 2019, 00:00

  • PND58 RISK FACTORS OF EARLY-ONSET DEMENTIA AMONG PEOPLE LIVING WITH HIV/AIDS: A CLAIMS DATA ANALYSIS

    May 1, 2019, 00:00

  • PDG2 EFFICACY OF PIOGLITAZONE IN IMPROVING LIVER HISTOLOGY SCORES OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC-REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PDB5 A SERIES OF BIOSTATISTICAL METHODOLOGICAL ANALYSIS ABOUT THE RELATION AMONG CLINICAL LABORATORY TESTS’ RESULTS

    May 1, 2019, 00:00

  • PND86 REPLICATION OF A US CLAIMS BASED ALGORITHM TO IDENTIFY MULTIPLE SCLEROSIS DISEASE SEVERITY BASED ON HEALTHCARE COSTS

    May 1, 2019, 00:00

  • PDB37 COST EFFECTIVENESS OF SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS, GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONISTS, DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PNS69 FACTORS ASSOCIATED WITH INITIATION OF E-CIGARETTE AMONG MIDDLE SCHOOL VS. HIGH SCHOOL CHILDREN

    May 1, 2019, 00:00

  • PDB124 REAL WORLD CHART REVIEW EXAMINATION OF LORCASERIN TREATMENT IN WEIGHT MANAGEMENT

    May 1, 2019, 00:00

  • PDB110 PATIENT ACTIVATION AND ANTIDIABETIC MEDICATION ADHERENCE AMONG MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PRO3 SUCCESSOR STUDY: TREATMENT AND HEALTH CARE RESOURCE UTILIZATION BY SICKLE CELL PATIENTS WHO PARTICIPATED IN THE SUSTAIN STUDY IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCV106 ADHERENCE TO SELF-CARE RECOMMENDATIONS AND ASSOCIATED FACTORS AMONG ADULT HEART FAILURE PATIENTS AT GONDAR UNIVERSITY REFERRAL HOSPITAL, NORTHWEST ETHIOPIA

    May 1, 2019, 00:00

  • PIN83 ADULT VACCINATION IN BRAZIL: A NATIONAL CROSS-SECTIONAL SURVEY ON PHYSICIANS PRESCRIPTION HABITS

    May 1, 2019, 00:00

  • PDB89 PREDICTIVE MODEL FOR BEHAVIOR CHANGE IN A MODIFIED TELEHEALTH DIABETES PREVENTION PROGRAM

    May 1, 2019, 00:00

  • PND79 SHARED DECISION MAKING AND USE OF DECISION AIDS IN MULTIPLE SCLEROSIS

    May 1, 2019, 00:00

  • PND87 CHARACTERISTICS OF MIGRAINE PATIENTS WITH MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORES IN REAL-WORLD CLINICAL PRACTICE

    May 1, 2019, 00:00

  • PCV104 PSYCHOMETRIC VALIDATION OF THE ‘GOOD DAY BAD DAY’ ITEM IN A NEUROGENIC ORTHOSTATIC HYPOTENSION (NOH) POPULATION

    May 1, 2019, 00:00

  • PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2019, 00:00

  • PMS38 TREATMENT UTILIZATION OF COMMERCIALLY INSURED PATIENTS UNDER 65 YEARS OF AGE DIAGNOSED WITH LATERAL EPICONDYLITIS

    May 1, 2019, 00:00

  • Health Technology Assessment Challenges in Oncology: 20 Years of Value in Health

    May 1, 2019, 00:00

  • PNS214 MEDICATION INVENTORY AND MANAGEMENT EFFICIENCIES MODELLED WITHIN A HEALTH-SYSTEM'S AFFILIATED OUTPATIENT CLINICS

    May 1, 2019, 00:00

  • PCN239 COMPARISON OF RESOURCE UTILIZATION AND POTENTIAL COST SAVINGS FOLLOWING SCREENING WITH DIGITAL BREAST TOMOSYNTHESIS COMPARED WITH DIGITAL MAMMOGRAPHY

    May 1, 2019, 00:00

  • PDB40 BUDGET IMPACT SAVINGS OF LIRAGLUTIDE 1,2MG VERSUS INSULIN IN ALGERIAN T2D PATIENTS INSUFFICIENTLY CONTROLLED WITH ORAL MEDICATIONS

    May 1, 2019, 00:00

  • PMU112 HOW TO OPERATIONALISE A FULLY ANONYMISED RETROSPECTIVE CHART REVIEW. A CASE STUDY FOR THE DEVOLVED NATIONS OF THE UNITED KINGDOM

    May 1, 2019, 00:00

  • PIH2 DEVELOPMENT AND VALIDATION OF A PATIENT CENTERED OUTCOME MEASURE FOR USE IN DEMENTIA DRUG TRIALS

    May 1, 2019, 00:00

  • PMH4 AN INDIRECT TREATMENT COMPARISON OF BREXPIPRAZOLE VERSUS LURASIDONE IN PATIENTS UNDERGOING ACUTE AND MAINTENANCE PHASE TREATMENT FOR SCHIZOPHRENIA

    May 1, 2019, 00:00

  • PCN250 SYSTEMATIC REVIEW OF VALIDATION STUDIES TO IDENTIFY LIVER, LUNG, BRAIN AND BONE METASTASES IN ADMINISTRATIVE CLAIMS DATA

    May 1, 2019, 00:00

  • Injury Process of Care

    May 1, 2019, 00:00

  • PCV113 DIFFERENCE-IN-DIFFERENCES ANALYSIS OF THE IMPACT OF ORAL ANTICOAGULANT PRESCRIBING ON INCIDENCE OF ATRIAL-FIBRILLATION-RELATED STROKE

    May 1, 2019, 00:00

  • PCN286 COMPARING EQ-5D-3L AND EQ-5D-5L PSYCHOMETRIC PROPERTIES OF COMMON CANCERS IN CHINA: A CROSS-SECTIONAL STUDY

    May 1, 2019, 00:00

  • PIN26 COST-MINIMIZATION ANALYSIS OF PAN-GENOTYPIC TREATMENT REGIMENS FOR CHRONIC HEPATITIS C

    May 1, 2019, 00:00

  • PCN243 REAL-TIME SYSTEMATIC LITERATURE REVIEWS (SLR) - DREAM OR REALITY WITH COMPUTER-ASSISTED METHODS: A CASE STUDY IN ACUTE MYELOID LEUKEMIA (AML)

    May 1, 2019, 00:00

  • PND36 LONGITUDINAL COMPARISON IN EMPLOYMENT BETWEEN MULTIPLE SCLEROSIS PATIENTS VERSUS CONTROLS

    May 1, 2019, 00:00

  • PNS247 PATIENT BURDEN TO FAMILY: AN EXAMINATION OF IMPORTANCE AND WORDING

    May 1, 2019, 00:00

  • PMH42 OPIOID MEDICATION UTILIZATION AND SPENDING IN MEDICARE PART D PROGRAM

    May 1, 2019, 00:00

  • PCN318 REAL WORLD TREATMENT DATA BASED PROJECTION OF PATIENT NUMBER ELIGIBLE FOR IMMUNO-ONCOLOGY THERAPIES IN TAIWAN AND ESTIMATION OF TOTAL LIFE YEARS GAINED

    May 1, 2019, 00:00

  • PCN264 QUALITY ADJUSTED TIME WITHOUT SYMPTOMS OF DISEASE PROGRESSION OR TOXICITY (Q-TWIST) OF NIVOLUMAB PLUS IPILIMUMAB (NIVO+IPI) VS SUNITINIB (SUN) AMONG UNTREATED ADVANCED RENAL CELL CARCINOMA (ARCC) PATIENTS (PATIENTS) WITH INTERMEDIATE ...

    May 1, 2019, 00:00

  • PMH48 DISPARITIES IN COGNITIVE IMPAIRMENT WITH ANTICHOLINERGIC DRUG USE: ANALYSIS OF THE REASONS FOR GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE (REGARDS) STUDY

    May 1, 2019, 00:00

  • PCV27 EXPLORING CHANGES IN UTILIZATION AND EXPENDITURES FOR LIPID-LOWERING AGENTS BETWEEN 2011 AND 2015

    May 1, 2019, 00:00

  • PNS38 THE VALUE OF PHARMACY INTEGRATION

    May 1, 2019, 00:00

  • PDB53 IS HIGHER-PRICED INSULIN ASSOCIATED WITH BETTER ECONOMIC AND HEALTH OUTCOMES? A STUDY FROM A VALUE-BASED PAYMENT PERSPECTIVE

    May 1, 2019, 00:00

  • PMD5 ASSOCIATION BETWEEN BUPRENORPHINE RETENTION/ADHERENCE AND HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS: A LITERATURE REVIEW

    May 1, 2019, 00:00

  • PCN266 PATIENT-REPORTED OUTCOMES IN LABELING FOR NOVEL ONCOLOGY AGENTS

    May 1, 2019, 00:00

  • PCN289 DELAY OR FOREGO OF TREATMENT AND ASSOCIATED SERVICES IN PATIENTS WITH CANCER: A MEDICAL EXPENDITURE PANEL SURVEY (MEPS) STUDY

    May 1, 2019, 00:00

  • PND40 BUDGET IMPACT ANALYSIS OF GALCANEZUMAB-GNLM FOR THE PREVENTIVE TREATMENT OF PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PND92 EXTENT AND FACTORS ASSOCIATED WITH ADHERENCE TO APPROPRIATE ANTIDEPRESSANT TREATMENT DURING ACUTE AND CONTINUATION PHASE DEPRESSION TREATMENT AMONG OLDER ADULTS WITH DEMENTIA AND MAJOR DEPRESSIVE DISORDER

    May 1, 2019, 00:00

  • PDB3 THE ASSOCIATION BETWEEN POST-THYROIDECTOMY SERUM TRIIODOTHYRONINE-TO-THYROXINE (T3/T4) RATIO AND INCIDENCE OF METABOLIC SYNDROME CONDITIONS

    May 1, 2019, 00:00

  • PNS177 A SYSTEMATIC REVIEW AND CONTENT ANALYSIS OF RHETORIC ABOUT THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) IN THE WRITTEN MEDIA, 2015-2017

    May 1, 2019, 00:00

  • PMS51 THE EFFECT OF WORK ABSENCES ON HEALTH SERVICES UTILIZATION AND COSTS AMONG EMPLOYED INDIVIDUALS WITH RHEUMATOID ARTHRITIS

    May 1, 2019, 00:00

  • PDB62 INCIDENCE AND COST OF DIABETES RELATED EVENTS IN AN ADULT TYPE 1 DIABETES POPULATION FROM A U.S. PAYOR PERSPECTIVE

    May 1, 2019, 00:00

  • PIN29 ESTIMATION OF THE CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) AS A TEST AND TREAT (TT) ANTIRETROVIRAL (ARV) REGIMEN FOR TREATMENT-NAIVE PATIENTS WITH HIV-1 INFECTION IN THE UNITED STATES

    May 1, 2019, 00:00

  • PDB44 INCREMENTAL HEALTHCARE EXPENDITURES ASSOCIATED WITH DYSLIPIDEMIA AMONG PATIENTS WITH THYROID DISEASES

    May 1, 2019, 00:00

  • PMH14 COST EFFICIENCY OF ESKETAMINE NASAL SPRAY VERSUS STANDARD OF CARE FOR TREATMENT RESISTANT DEPRESSION

    May 1, 2019, 00:00

  • PNS213 A NEW TOOL TO IMPROVE NETWORK META-ANALYSES OF SURVIVAL DATA IN HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2019, 00:00

  • PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC

    May 1, 2019, 00:00

  • PDB73 WHAT IS THE LIFE-EXPECTANCY FOR DIABETICS IN BULGARIA?

    May 1, 2019, 00:00

  • PCV71 CLINICAL AND ECONOMIC PROFILE OF PATIENTS WITH ACUTE AND CHRONIC HEART FAILURE IN USUAL CLINICAL PRACTICE

    May 1, 2019, 00:00

  • PCN263 PROGNOSTIC VALUE OF HEALTH-RELATED QUALITY OF LIFE ON OVERALL SURVIVAL IN OLDER AMERICANS WITH KIDNEY CANCER: A POPULATION-BASED COHORT STUDY

    May 1, 2019, 00:00

  • PDG64 OPTIMISING ANTIBIOTIC PRESCRIBING IN DEVELOPING COUNTRIES

    May 1, 2019, 00:00

  • PNS111 SURVEY RESULTS OF CONTEMPORARY U.S. HEALTH PLAN POLICIES: NEW CHALLENGES, DIGITAL TECHNOLOGIES, VALUE-BASED CONTRACTING, AND COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2019, 00:00

  • PIN64 COMPLETE ADHERENCE TO ANTIRETROVIRAL THERAPY AMONG HIV-INFECTED ADULTS RECEIVING MEDICAL CARE: INFLUENCE OF DURATION SINCE HIV DIAGNOSIS

    May 1, 2019, 00:00

  • PCV43 ECONOMIC VALUATION OF INFORMAL CARE PROVIDED TO PEOPLE AFTER A MYOCARDIAL INFARCTION IN FRANCE

    May 1, 2019, 00:00

  • PMH23 BUDGET IMPACT ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES

    May 1, 2019, 00:00

  • NO Specific Disease - Methodological Statistical Research

    May 1, 2019, 00:00

  • PND57 THE SOCIETAL BURDEN OF PRODROMAL ALZHEIMER’S DISEASE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS232 ARE VIDEOS OR TEXT BETTER FOR DESCRIBING ATTRIBUTES IN STATED-PREFERENCE SURVEYS? SOME EXPERTS WILL BE SURPRISED

    May 1, 2019, 00:00

  • PDG56 THE EFFECTIVENESS OF ENROLLMENT TYPE IN PRESCRIPTION DRUG MONITORING PROGRAMS: A RETROSPECTIVE STUDY

    May 1, 2019, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59 (current)
  • 60
  • »